Watertown, MA, United States of America

Tarek A Zeidan

This inventor holds 49 USPTO granted patents and 14 published patent applications, plus 12 CIPO patents and 15 EPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Alkermes Pharma Ireland Limited. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tarek A Zeidan. Retrieved from https://idiyas.com/inventor/tarek-a-zeidan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 49 

% Patents Active = 93.9

 

 

Average Co-Inventor Count = 4.2

ph-index = 10

Forward Citations = 359(Granted Patents)


Location History:

  • Waltham, MA (US) (2018 - 2021)
  • Watertown, MA (US) (2013 - 2022)
  • Lexington, MA (US) (2017 - 2024)

Company Filing History:


Years Active: 2013-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Heterocyclic Compounds
Prodrugs
Fumarates
Aripiprazole
Psychological Disorders
Neurological Disorders
Crystallization Process
Oxidized Lactam Compounds
Multi-API Loading
NH-Acidic Compounds
Extended Release Formulations
Secondary Amine Compounds
49 patents (USPTO):Explore Patents

Title: Unveiling the Inventive Journey of Tarek A Zeidan

Introduction:

Tarek A Zeidan, a prolific inventor based in Watertown, MA (US), has made significant contributions to the field of healthcare through his groundbreaking patents and innovative work. With an impressive tally of 45 patents to his name, Zeidan stands out as a visionary in the realm of pharmaceutical advancements.

Latest Patents:

Among his latest patents, two notable inventions highlight Zeidan's commitment to enhancing treatment methodologies for neurological disorders and mental health conditions. The first patent revolves around the development of prodrugs of fumarates for treating a range of neurological diseases, including multiple sclerosis. The second patent delves into a crystallization process of aripiprazole derivatives in extended-release formulations, particularly for the treatment of schizophrenia.

Career Highlights:

Tarek A Zeidan currently lends his expertise to Alkermes Pharma Ireland Limited, a leading pharmaceutical company at the forefront of drug development and innovation. Within the company, Zeidan has played a pivotal role in spearheading research projects that have the potential to revolutionize the treatment landscape for various medical conditions.

Collaborations:

In his professional journey, Zeidan has collaborated closely with esteemed colleagues such as Laura Cook Blumberg and Julius F Remenar. Together, they have synergized their knowledge and skills to push the boundaries of pharmaceutical research and pave the way for novel therapeutic solutions.

Conclusion:

In conclusion, Tarek A Zeidan emerges as a trailblazing inventor whose relentless pursuit of excellence has led to the creation of groundbreaking patents in the pharmaceutical domain. His innovative spirit, coupled with his strategic collaborations and industry expertise, cements Zeidan's reputation as a driving force in the realm of healthcare advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…